Group Members

Brian Kirby
Brian Kirby
Principal Investigator

About The Kirby Lab

Keywords: Inflammatory Skin Diseases, Psoriasis, Hidradenitis Suppourativa, Biologics, Clinical trials.

Our research is focused on the study of systemic and tissue-specific inflammation in common human inflammatory skin diseases (especially psoriasis and hidradenitis suppurativa), from both laboratory and clinical perspectives.


Recent Publications
  1. Gilhooley E, O'Grady C, Roche D, Mahon JM, Hambly R, Kelly A, Dhonncha EN, Moriarty B, Connolly M, Kirby B, Tobin AM, Ryan C. High Levels of Psychological Distress, Sleep Disturbance, and Alcohol Use Disorder in Adults With Atopic Dermatitis. Dermatitis. 2020 Dec 15;Publish Ahead of Print. DOI: 10.1097/DER.0000000000000687. Epub ahead of print. 
  2. Zouboulis CC, Gulliver W, Ingram J, Kirby B, Giamarellos-Bourboulis EJ, Podda M, Tzellos T, Jemec GBE. Endpoints of clinical trials for Hidradenitis Suppurativa: Proceedings of a round-table session. Exp Dermatol. 2020 Jul;29 Suppl 1:67-72. DOI: 10.1111/exd.14123. 
  3. Gatault S, Kirby B, Danso-Abeam D. Comment on "Olmsted Syndrome". Case Rep Dermatol Med. 2020 Jun 3;2020:8024981. DOI: 10.1155/2020/8024981.  
  4. Kirby B, Fitzgerald O. A new biomarker for psoriatic arthritis? Br J Dermatol. 2020 Nov;183(5):805-806. DOI: 10.1111/bjd.19141. Epub 2020 May 12. 
  5. Murray G, Hollywood A, Kirby B, Hughes R. Dapsone therapy for hidradenitis suppurativa. Br J Dermatol. 2020 Oct;183(4):767-768. DOI: 10.1111/bjd.19136. Epub 2020 Jun 8
  6. Kearney N, Byrne N, Kirby B, Hughes R. Successful use of guselkumab in the treatment of severe hidradenitis suppurativa. Clin Exp Dermatol. 2020 Jul;45(5):618-619. DOI: 10.1111/ced.14199. Epub 2020 Mar 30.
  7. Musilova J, Moran B, Sweeney CM, Malara A, Zaborowski A, Hughes R, Winter DC, Fletcher JM, Kirby B. Enrichment of Plasma Cells in the Peripheral Blood and Skin of Patients with Hidradenitis Suppurativa. J Invest Dermatol. 2020 May;140(5):1091-1094.e2. DOI: 10.1016/j.jid.2019.08.453. Epub 2019 Nov 1.
  8. Warren RB, Barker JNWB, Finlay AY, Burden AD, Kirby B, Armendariz Y, Williams R, Hatchard C, Khare S, Griffiths CEM. Secukinumab for patients failing previous tumour necrosis factor-α inhibitor therapy: results of a randomized open-label study (SIGNATURE). Br J Dermatol. 2020 Jul;183(1):60-70. DOI: 10.1111/bjd.18623. Epub 2019 Dec 25.
  9. Lynch M, Malara A, Timoney I, Ahern T, Awdeh F, Sweeney C, Galligan M, Venckens S, Kelly G, Hughes R, O Apos Shea D, Doran P, Kirby B. Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients with Diabetes: A Double-Blind Randomized Controlled Trial. Dermatology. 2021;237(1):66-69. DOI: 10.1159/000502130. Epub 2019 Aug 30. 
  10. Byrne N, Hughes R, Murphy LA, Kirby B. Remission of severe hidradenitis suppurativa following chemotherapy for Hodgkin lymphoma. Br J Dermatol. 2020 Feb;182(2):483-484. DOI: 10.1111/bjd.18423 Epub 2019 Oct 9. 
  11. Jennings L, Hambly R, Hughes R, Moriarty B, Kirby B. Metformin use in hidradenitis suppurativa. J Dermatolog Treat. 2020 May;31(3):261-263. DOI: 10.1080/09546634.2019.1592100. Epub 2019 Mar 25. 

Former Students

  • Oonagh Molloy